Key result
Complete revascularization (grafts to ≥3 vessels) improved 6-year survival compared to 2 vessels in patients with severe angina and ejection fraction <0.35 (69% vs 45%, p=0.04).
Why the study?
Does complete revascularization improve survival and event-free survival in patients with three-vessel coronary disease undergoing coronary artery bypass surgery?
Population
3,372 nonrandomized surgical patients from the Coronary Artery Surgery Study Registry with three-vessel…
Comparison
Complete revascularization vs Incomplete revascularization
Design
Cohort
Follow-up
up to 6 years
Authors
Loading...
Supports complete revascularization in severe angina with EF<0.35; leaves open need for randomized confirmation in three-vessel disease.
Cohort (n=3,372)
Yes
Does complete revascularization improve survival and event-free survival in patients with three-vessel coronary disease undergoing coronary artery bypass surgery?
Absolute Event Rate: 69% vs 45%
p-value: p=0.04
Complete revascularization during CABG in patients with three-vessel disease provides the greatest survival and event-free survival benefits to those with severe angina and left ventricular dysfunction.
Bell et al. (1992) conducted a cohort in Three-vessel coronary disease (n=3,372). Complete revascularization (grafts to ≥3 vessels) vs. Less complete revascularization (grafts to 1 or 2 vessels) was evaluated on 6-year survival in patients with severe angina and ejection fraction <0.35 (p=0.04). Complete revascularization (grafts to ≥3 vessels) improved 6-year survival compared to 2 vessels in patients with severe angina and ejection fraction <0.35 (69% vs 45%, p=0.04).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: